This antibody was purified from culture supernatant using protein A agarose. This hybridoma (clone 5G5) was established by fusion of mouse myeloma cell P3X with C57BL/6 mouse splenocyte immunized with the recombinant human TLR9 (1-815 aa).
Target:
TLR9
Application Dilute:
FCM: 10 ug/mL (final concentration)
* VAT and and shipping costs not included. Errors and price changes excepted